Vincasar PFS
Brand names,
Vincasar PFS
Analogs
Vincasar PFS
Brand Names Mixture
Vincasar PFS
Chemical_Formula
C46H56N4O10
Vincasar PFS
RX_link
http://www.rxlist.com/cgi/generic3/vincristine.htm
Vincasar PFS
fda sheet
Vincasar PFS
msds (material safety sheet)
Vincasar PFS
Synthesis Reference
No information avaliable
Vincasar PFS
Molecular Weight
824.958 g/mol
Vincasar PFS
Melting Point
220 oC
Vincasar PFS
H2O Solubility
No information avaliable
Vincasar PFS
State
Solid
Vincasar PFS
LogP
4.918
Vincasar PFS
Dosage Forms
Liquid; Solution
Vincasar PFS
Indication
For treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia, acute panmyelosis
Vincasar PFS
Pharmacology
Vincristine is a vinca alkaloid antineoplastic agent used as a treatment for various cancers including breast cancer, Hodgkin's disease, Kaposi's sarcoma, and testicular cancer. The vinca alkaloids are structurally similar compounds comprised of 2 multiringed units, vindoline and catharanthine. The vinca alkaloids have become clinically useful since the discovery of their antitumour properties in 1959. Initially, extracts of the periwinkle plant (Catharanthus roseus) were investigated because of putative hypoglycemic properties, but were noted to cause marrow suppression in rats and antileukemic effects in vitro. Vincristine binds to the microtubular proteins of the mitotic spindle, leading to crystallization of the microtubule and mitotic arrest or cell death. Vincristine has some immunosuppressant effect. The vinca alkaloids are considered to be cell cycle phase-specific.
Vincasar PFS
Absorption
No information avaliable
Vincasar PFS
side effects and Toxicity
IVN-RAT LD50 1300 mg/kg; IPR-MUS LD50 5.2 mg/kg
Vincasar PFS
Patient Information
PATIENT INFORMATION
Follow the links
http://www.rxlist.com/cgi/generic3/vincristine_wcp.htm
http://www.drugs.com/cons/Vincristine.html
Vincasar PFS
Organisms Affected
Humans and other mammals